BIOTEMPUS AND CANCER TREATMENT IN DOGS.

Melbourne based biotechnology company Biotempus has made a remarkable discovery: cancer patients’ [both canine and human] immune systems run on a cycle and thus delivering treatment at the wrong times could be reducing the efficacy. Dr Noam Pik, the general manager at ASAP Laboratory, explained they hypothesised that a seven-day cycle was the key to the efficacy of treatment by building on previous medical research. “This discovery was made by Martin Ashdown while investigating AIDS with mice after noticing some responded better to the same treatment at different times post inoculation,” said Dr Pik. “This lead to the hypothesis that the immune system operates differently in the time domain. That is, at certain times it is more effective at eliminating disease.” Read more here; vetpracticemag.com.au/on-the-cusp-of-a-breakthrough/